LB Pharmaceuticals Inc. (LBRX)

LB Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2024	Dec 31, 2023
Cash & Equivalents	14.23	22.98	14.98
Short-Term Investments	-	5.02	28.31
Cash & Cash Equivalents	14.23	28	43.29
Cash Growth	-	-35.32%	-
Other Current Assets	0.56	0.88	2.34
Total Current Assets	14.78	28.88	45.63
Property, Plant & Equipment	-	1.86	0.02
Goodwill and Intangibles	-	2.3	-
Other Long-Term Assets	-	0.5	0
Total Long-Term Assets	-	4.66	0.02
Total Assets	-	33.53	45.66
Accounts Payable	-	2.32	1.39
Current Debt	-	0.49	-
Other Current Liabilities	3.91	5.3	1.22
Total Current Liabilities	3.91	8.11	2.61
Long-Term Debt	-	3.22	-
Other Long-Term Liabilities	-	2.5	1.56
Total Long-Term Liabilities	-	5.72	1.56
Total Liabilities	-	13.83	4.16
Total Debt	3.76	3.7	0
Retained Earnings	-	-104.32	-41.22
Comprehensive Income	-	0.11	0.27
Shareholders' Equity	-103.87	-94.55	-34.47
Net Cash (Debt)	10.46	24.3	43.29
Net Cash (Debt) Growth	-	-43.88%	-
Working Capital	10.88	20.77	43.03

Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).